Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen for Preventing ICU Admission in COVID-19
NCT04327505Phase 3Terminated
- Sponsor
- Karolinska Institutet
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 2
01
Overview
A Phase 3 trial of hyperbaric oxygen therapy in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Karolinska Institutet. Started Jun 2020; status: terminated.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04327505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04327505.